Drug lookup
Drug reference

imipramine

TCA · Antidepressant

Also known as imipramine hydrochloride

TCAAntidepressant
CDSCO approvedSchedule H
EXCRETION
not curated
INTERACTIONS
12 major
incl. contraindicated
PREGNANCY
Manufacturer advises avoid.
FDA category + note
Top interactionssee all 12
  • MoclobemideContraindicatedTextbookG&G 14e
  • CodeineSevereTextbook-citedKDT 7e · p950
  • EpinephrineSevereTextbook-citedKDT 7e · p950
  • MorphineSevereTextbook-citedKDT 7e · p950

Mechanism

Tricyclic and related antidepressants block the re-uptake of both serotonin and noradrenaline. Imipramine hydrochloride is more selective for noradrenergic transmission.

Indications

Panic disorder (second-line, unlicensed)depressionpsychotic depression (with first-generation antipsychotics)pain conditionsSleep Enuresis

Dosing

Adult
doses that are sufficiently high for effective treatment but not so high as to cause toxic effects. Low doses should be used for initial treatment in the elderly. In most patients the long half-life of tricyclic antidepressant drugs allows oncedaily administration, usually at night; the use of modifiedrelease preparations is therefore unnecessary.…

Pharmacokinetics

Half-life
12 hours (parent), 30 hours (active metabolite)
Bioavailability
Imipramine exhibits high first-pass metabolism.
Protein binding
Imipramine's rate of metabolism is limited by hepatic blood flow.
Metabolism
hepatic (CYP2D6, CYP2C19, CYP3A3/4, CYP1A2)

Side effects

Common
antimuscarinic side-effectssedationcognitive dullingblurred visiondry mouthtachycardiaconstipationdifficulty urinatingorthostatic hypotensionweight gain
Serious
  • cardiotoxicity in overdosage
  • quinidine-like effects on cardiac conduction (life threatening in overdose)
  • lowered seizure threshold
  • serotonin syndrome (with MAOIs)
  • cardiac arrhythmia (overdose)

Pregnancy & lactation

Pregnancy

Manufacturer advises avoid.

Drug interactions

Moclobemide
Contraindicated
Textbook

Increased risk of serotonin syndrome and potentiated sympathomimetic effects.

Should not be used concurrently with MAOIs or within 14 days of stopping MAOIs.

Source: G&G 14e

Codeine
Severe
Textbook-cited

Enhanced sedation and respiratory depression

Avoid concurrent use

Source: KDT 7e · p950

Epinephrine
Severe
Textbook-cited

Exaggerated hypertensive response

Use local anaesthetic without adrenaline in patients on TCAs

Source: KDT 7e · p950

Morphine
Severe
Textbook-cited

Excessive sedation and respiratory depression; potentially fatal.

Avoid concurrent use

Source: KDT 7e · p950

Pethidine
Severe
Textbook-cited

Severe sedation and respiratory depression

Avoid concurrent use

Source: KDT 7e · p950

Adrenaline
Severe
Textbook

Potentiation of adrenaline's effects.

Vasoconstrictor (adrenaline) containing LA should be avoided in patients receiving tricyclic antidepressants.

Source: KDT 7e · p365

Artemisinins
Severe
Textbook

Increased risk of cardiac conduction defects.

Source: KDT 7e · p816-835

Meglumine Antimoniate
Severe
Textbook

Increased cardiotoxicity (e.g., QT prolongation).

Source: Harrison 22e · p1740

Amiodarone
Severe
Database

Drug interaction classified as: synergy

Source: DDInter

Amisulpride
Severe
Database

Drug interaction classified as: synergy

Source: DDInter

Anagrelide
Severe
Database

Drug interaction classified as: synergy

Source: DDInter

Arbutamine
Severe
Database

Drug interaction classified as: synergy

Source: DDInter

Related guidelines

Other TCA drugs

Ask House about imipramine

Continue into a citation-backed clinical answer with the drug context already attached.

Sources: KD Tripathi 7e, Goodman & Gilman 14e, Harrison 22e, BNF·Verified: 2026-05-13 · House clinical team